RaySearch Laboratories is setting a new standard in precision oncology by unveiling its latest software advancements at PTCOG 63 in Buenos Aires. The company’s flagship platforms—RayStation®, RayCare®, RayIntelligence®, and RayCommand®—showcase a deeply integrated ecosystem that transforms particle therapy into a smarter, more adaptable treatment solution. Among the highlights is the clinically applied proton arc therapy, which enhances dose conformity and spares healthy tissue, marking a leap forward in radiotherapy effectiveness. Additionally, the ultra-fast, GPU-based Monte Carlo dose engine and robust optimization tools streamline complex calculations without compromising accuracy, making cutting-edge treatments more accessible and efficient.
These innovations are not just theoretical but highly practical in clinical use. RayStation now supports upright treatment planning, beneficial for facilities using fixed beamlines and for patients needing improved comfort. Its latest updates include automated replanning, AI-based segmentation, and the new ECHO automated planning algorithm, originally developed at Memorial Sloan Kettering. RayCare complements this by connecting every stage of the oncology workflow, improving communication, coordination, and reducing manual intervention. RayIntelligence provides the critical layer of analytics, transforming fragmented clinical data into actionable insights for improved outcomes and operational efficiency.
In conclusion, RaySearch is pushing the boundaries of cancer care through its cohesive, forward-looking software suite. The seamless integration of treatment planning, workflow orchestration, data analytics, and machine interfacing reflects a commitment to advancing particle therapy for real-world clinical environments. By empowering clinicians with precise tools and streamlined processes, RaySearch is helping to improve patient care and accelerate the adoption of next-generation radiotherapy worldwide.
MedTech Spectrum's Summary
RaySearch’s software suite—RayStation®, RayCare®, RayIntelligence®, and RayCommand®—offers a fully integrated, AI-enhanced ecosystem that optimizes every stage of particle therapy, from planning to treatment execution.
Breakthroughs such as proton arc therapy, GPU-based Monte Carlo dose engines, and adaptive replanning significantly improve dose accuracy, patient comfort, and workflow efficiency in real-world clinical settings.
With data-driven insights, smart automation, and seamless connectivity, RaySearch is empowering clinicians to deliver more effective, personalized, and scalable cancer treatments—marking a major advancement in global oncology practice.